Quinolines
"Quinolines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Descriptor ID |
D011804
|
MeSH Number(s) |
D03.438.810
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Quinolines".
Below are MeSH descriptors whose meaning is more specific than "Quinolines".
This graph shows the total number of publications written about "Quinolines" by people in this website by year, and whether "Quinolines" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 1 | 1 | 2 | 2001 | 1 | 0 | 1 | 2002 | 1 | 0 | 1 | 2003 | 1 | 0 | 1 | 2004 | 1 | 0 | 1 | 2005 | 2 | 0 | 2 | 2006 | 2 | 0 | 2 | 2007 | 1 | 0 | 1 | 2008 | 0 | 1 | 1 | 2009 | 3 | 1 | 4 | 2010 | 1 | 0 | 1 | 2011 | 0 | 2 | 2 | 2012 | 1 | 0 | 1 | 2013 | 1 | 0 | 1 | 2016 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Quinolines" by people in Profiles.
-
Loftus LM, White JK, Albani BA, Kohler L, Kodanko JJ, Thummel RP, Dunbar KR, Turro C. New Ru(II) Complex for Dual Activity: Photoinduced Ligand Release and (1)O2 Production. Chemistry. 2016 Mar 07; 22(11):3704-8.
-
Mohedas AH, Xing X, Armstrong KA, Bullock AN, Cuny GD, Yu PB. Development of an ALK2-biased BMP type I receptor kinase inhibitor. ACS Chem Biol. 2013; 8(6):1291-302.
-
Gorski A, Gawinkowski S, Herbich J, Krauss O, Brutschy B, Thummel RP, Waluk J. 1H-pyrrolo[3,2-h]quinoline: a benchmark molecule for reliable calculations of vibrational frequencies, IR intensities, and Raman activities. J Phys Chem A. 2012 Dec 06; 116(48):11973-86.
-
Martinez LA, Tejada-Simon MV. Pharmacological inactivation of the small GTPase Rac1 impairs long-term plasticity in the mouse hippocampus. Neuropharmacology. 2011 Jul-Aug; 61(1-2):305-12.
-
Bhagunde P, Singh R, Ledesma KR, Chang KT, Nikolaou M, Tam VH. Modelling biphasic killing of fluoroquinolones: guiding optimal dosing regimen design. J Antimicrob Chemother. 2011 May; 66(5):1079-86.
-
Hellal M, Cuny GD. Synthesis of the indolizino[7,6-c]quinoline alkaloid isaindigotidione. Org Lett. 2010 Oct 15; 12(20):4628-31.
-
Hu B, Bernotas R, Unwalla R, Collini M, Quinet E, Feingold I, Goos-Nilsson A, Wilhelmsson A, Nambi P, Evans M, Wrobel J. Quinoline-3-carboxamide containing sulfones as liver X receptor (LXR) agonists with binding selectivity for LXRbeta and low blood-brain penetration. Bioorg Med Chem Lett. 2010 Jan 15; 20(2):689-93.
-
Xu H, Kulkarni KH, Singh R, Yang Z, Wang SW, Tam VH, Hu M. Disposition of naringenin via glucuronidation pathway is affected by compensating efflux transporters of hydrophilic glucuronides. Mol Pharm. 2009 Nov-Dec; 6(6):1703-15.
-
Bernotas RC, Singhaus RR, Kaufman DH, Travins JM, Ullrich JW, Unwalla R, Quinet E, Evans M, Nambi P, Olland A, Kauppi B, Wilhelmsson A, Goos-Nilsson A, Wrobel J. 4-(3-Aryloxyaryl)quinoline sulfones are potent liver X receptor agonists. Bioorg Med Chem Lett. 2010 Jan 01; 20(1):209-12.
-
Singh R, Ledesma KR, Chang KT, Hou JG, Prince RA, Tam VH. Pharmacodynamics of moxifloxacin against a high inoculum of Escherichia coli in an in vitro infection model. J Antimicrob Chemother. 2009 Sep; 64(3):556-62.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|